# Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function

> **NCT04865393** · PHASE1 · COMPLETED · sponsor: **Spero Therapeutics** · enrollment: 37 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** SPR206

## Key facts

- **NCT ID:** NCT04865393
- **Lead sponsor:** Spero Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-08
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865393, "Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04865393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*